[HTML][HTML] Personalised medicine in interstitial lung diseases: Number 6 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and …
MA Kokosi, GA Margaritopoulos… - European Respiratory …, 2018 - Eur Respiratory Soc
… personalised medicine in IPF and other ILDs comes primarily from data in other chronic lung
diseases… biomarkers that might lead to a personalised approach in future. Given these data, …
diseases… biomarkers that might lead to a personalised approach in future. Given these data, …
COPD phenotypes and biomarkers: Introducing personalised medicine
AG Mathioudakis… - Current Respiratory …, 2013 - ingentaconnect.com
… disease. The recognition of all these prognostic and therapeutic patient subgroups lead to a
more personalised approach to … The proportional Venn diagram of obstructive lung disease: …
more personalised approach to … The proportional Venn diagram of obstructive lung disease: …
[HTML][HTML] Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an …
A Kacprzak, W Tomkowski, M Szturmowicz - Diagnostics, 2023 - mdpi.com
… Pulmonary hypertension (PH) due to lung diseases … lung diseases (ILDs) is 3.5–15% at
an early stage, 30–50% at the time of advanced disease, and 60–90% in patients listed for lung …
an early stage, 30–50% at the time of advanced disease, and 60–90% in patients listed for lung …
[HTML][HTML] Biomarkers for acute respiratory distress syndrome and prospects for personalised medicine
S Spadaro, M Park, C Turrini, T Tunstall… - Journal of …, 2019 - Springer
… to assess the application of metabolomics to lung disease, progress has been slow [54]. …
of inflammatory lung diseases, including ARDS [85, 86]. With a view to lung regeneration, …
of inflammatory lung diseases, including ARDS [85, 86]. With a view to lung regeneration, …
Respiratory healthcare by design: computational approaches bringing respiratory precision and personalised medicine closer to bedside
H Kaul - Morphologie, 2019 - Elsevier
… with lung mechanics to understand respiratory pathology at a systems level. This is significant
as this approach … have already made contributions to personalised healthcare and how the …
as this approach … have already made contributions to personalised healthcare and how the …
Personalised medicine for asthma and chronic obstructive pulmonary disease
LG Heaney, LPA McGarvey - Respiration, 2017 - karger.com
… This is a further example of where a personalised approach is critical in addressing the …
Matrix metalloproteases exert tissue-damaging effects in lung disease and are implicated in the …
Matrix metalloproteases exert tissue-damaging effects in lung disease and are implicated in the …
Exacerbations in COPD: a personalised approach to care
JJ Soler-Cataluña, M Miravitlles… - The Lancet …, 2023 - thelancet.com
… definitions, we propose a shift from an event-centred definition to an approach focused on
… , which might be the result of different disease mechanisms. In this proposal from the ANTES …
… , which might be the result of different disease mechanisms. In this proposal from the ANTES …
Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis?
DL Clarke, LA Murray, B Crestani… - Pharmacology & …, 2017 - Elsevier
… in their disease progression. Below we review the ongoing quest for novel therapeutic
approaches … pulmonary disease (COPD), another chronic lung disease associated with significant …
approaches … pulmonary disease (COPD), another chronic lung disease associated with significant …
The impact of personalised therapies on respiratory medicine
JS Elborn - European Respiratory Review, 2013 - Eur Respiratory Soc
… approaches to non-malignant respiratory disease presents exciting possibilities, and has
already led to new approaches … chronic obstructive pulmonary disease, asthma, lung fibrosis or …
already led to new approaches … chronic obstructive pulmonary disease, asthma, lung fibrosis or …
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management
… for Chronic Obstructive Lung Disease reorganised treatment … to target a personalised medicine
approach. Another challenge … the need for new treatment approaches in conjunction with …
approach. Another challenge … the need for new treatment approaches in conjunction with …
相关搜索
- interstitial lung diseases series personalised medicine
- pulmonary hypertension lung disease
- management of cystic fibrosis lung disease
- chronic interstitial lung diseases
- exacerbations in copd personalised approach
- interstitial lung diseases renaud louis
- dominant cause personalised approach
- effective therapy personalised approach
- interstitial lung diseases nicolas roche
- drug developments fibrosis lung disease
- treatable traits interstitial lung disease
- drug development initiative interstitial lung disease
- consensus statement interstitial lung disease
- interstitial lung diseases personalised approach
- precision medicine approach interstitial lung disease
- interstitial lung disease associated pulmonary hypertension